Latest news
Dyne Therapeutics (DYN) Gets FDA Clearance With Valuation Questions Back In Focus - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:35:42 GMTTribute Wall | Diane Van Dyne - Thomas Funeral HomesThomas Funeral Homes · Fri, 07 Aug 2026 10:09:51 GMTDyne Therapeutics, Inc. Revenue Breakdown – NASDAQ:DYN - TradingViewTradingView · Thu, 06 Aug 2026 23:21:02 GMTFMR LLC (DYN) discloses 6.8% Dyne Therapeutics stake in amended ownership filing - Stock TitanStock Titan · Thu, 06 Aug 2026 14:21:56 GMTRaymond James Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Raises Target Price to $40 - MoomooMoomoo · Wed, 05 Aug 2026 09:31:00 GMTHow FDA Greenlight For DYNE-302 And Equity Raise At Dyne Therapeutics (DYN) Has Changed Its Investment Story - simplywall.stsimplywall.st · Mon, 03 Aug 2026 20:53:00 GMTDyne Therapeutics, Inc. Stock 12‑Month Price Target Raised to $39.53, Implies 58% Upside - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMTDyne Therapeutics reports Q2 net loss $178.6M, cash $898.5M; BLA for z-rostudirsen accepted with PDUFA Jan 21, 2027 - TradingViewTradingView · Wed, 29 Jul 2026 20:43:04 GMT